Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentNeglected filovirusesEpigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus VaccineBolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineHIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in MiceHepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains.Increased Valency of Conserved-mosaic Vaccines Enhances the Breadth and Depth of Epitope Recognition.Integrated sequence and immunology filovirus database at Los AlamosInduction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.Towards the knowledge-based design of universal influenza epitope ensemble vaccines.Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.Vaccine design: emerging concepts and renewed optimism.Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.Polyvalent vaccine approaches to combat HIV-1 diversityGraph-based optimization of epitope coverage for vaccine antigen design.
P2860
Q24597625-59DDFD63-7CA4-4D03-91F5-C2CF0E997FC0Q28383265-5FD6D2B4-CE52-4A7B-ABF2-6A5CA125B6A0Q28822525-C0936F1F-4E98-4F8C-B312-881945A1261BQ35917496-ABAC41B4-21FA-4242-88C1-2BC738337D76Q36079913-3749512C-A11A-4A4B-87C0-A54842C85432Q36606741-3C31C9CD-19F8-4AA9-BDC6-16B2037FCA12Q36756865-CAC591B6-AEFB-4D2F-AFDD-3780ED381011Q36821995-D4CE7E70-2F19-4B03-B745-1034D70785DEQ36995725-81FC4206-9CA9-4970-9A09-17FE8059889BQ37365222-5E4BDF09-DFC4-4637-9B38-2204D1048A91Q37625296-2E7EB236-E2BB-43CB-9CF0-FE9C3FA43AF6Q38087785-D19F7DCB-5804-4CB6-B59C-2FD7D4DB5130Q38878840-464DC7AC-EF00-4F8A-B1BF-A9DCF07DDF59Q39108740-C5543A2F-2BF4-4702-9E23-AAE77C162DCCQ40354550-C93E1925-0008-454E-9B8A-32D68CDED73A
P2860
Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@ast
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@en
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@nl
type
label
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@ast
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@en
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@nl
prefLabel
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@ast
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@en
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@nl
P2093
P2860
P50
P1433
P1476
Designing and testing broadly- ...... T-lymphocyte epitope coverage
@en
P2093
Carla Kuiken
Hyejin Yoon
James R Thurmond
Karina Yusim
Majidat A Muhammad
Mary Kate Hart
Michael Parker
Paul W Fenimore
Russell R Bakken
P2860
P304
P356
10.1371/JOURNAL.PONE.0044769
P407
P577
2012-10-03T00:00:00Z